Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Biomarkers and Molecular Targets in ALL.

Current hematologic malignancy reports - 1 Feb 2024

De Sa Hong, Leonard Jessica

Abstract excerpt

PURPOSE OF REVIEW: Acute lymphoblastic leukemia (ALL) is a widely heterogeneous disease in terms of genomic alterations, treatment options, and prognosis. While ALL is considered largely curable in children, adults tend to have higher risk disease subtypes and do not respond as favorably to conventional chemotherapy. Identifying genomic drivers of leukemogenesis and applying targeted therapies in an effort to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Child
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Prognosis

Source

Identifiers

PMID: 38048037
DOI: 10.1007/s11899-023-00718-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Biomarkers and Molecular Targets in ALL.PMID 38048037Read ↗

T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatmentsSemantic proximity Read ↗

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.Semantic proximity Read ↗

Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Semantic proximity Read ↗

Advances in the Biology of Acute Lymphoblastic Leukemia—From Genomics to the ClinicSemantic proximity Read ↗

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicineSemantic proximity Read ↗

Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.Semantic proximity Read ↗

Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.Semantic proximity Read ↗

Genomic Subclassification and Risk Stratification of ALL.Semantic proximity Read ↗

B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classificationSemantic proximity Read ↗

Next-Generation Sequencing in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.Semantic proximity Read ↗

Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.